Cargando…
Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology
BACKGROUND: Pulmonary arterial hypertension (PAH) is a vasculopathy characterized by enhanced pulmonary artery smooth muscle cell (PASMC) proliferation and suppressed apoptosis. This results in both increase in pulmonary arterial pressure and pulmonary vascular resistance. Recent studies have shown...
Autores principales: | Meloche, Jolyane, Courchesne, Antony, Barrier, Marjorie, Carter, Sophie, Bisserier, Malik, Paulin, Roxane, Lauzon‐Joset, Jean‐François, Breuils‐Bonnet, Sandra, Tremblay, Ève, Biardel, Sabrina, Racine, Christine, Courture, Christian, Bonnet, Pierre, Majka, Susan M., Deshaies, Yves, Picard, Frédéric, Provencher, Steeve, Bonnet, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603259/ https://www.ncbi.nlm.nih.gov/pubmed/23525442 http://dx.doi.org/10.1161/JAHA.112.005157 |
Ejemplares similares
-
Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011) -
DNA Damage and Pulmonary Hypertension
por: Ranchoux, Benoît, et al.
Publicado: (2016) -
STAT3 signaling in pulmonary arterial hypertension
por: Paulin, Roxane, et al.
Publicado: (2012) -
Signal transduction in the development of pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2013) -
Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)